Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
immunology and microbiology
Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection
Virology, Volume 403, No. 1, Year 2010
Notification
URL copied to clipboard!
Description
Viral mutations at Gag residue 242 and relevant viral polymorphisms were analyzed in a cohort of 42 individuals with primary HIV-1 subtype C infection using single-genome amplification/sequencing. In HLA-B57/5801-negative subjects infected with 242N escape variant, reversion to Asn appeared at median (IQR) 103. days (97-213. days) post-seroconversion (p/s) and became dominant at 193. days (170-215. days) p/s. In subjects expressing HLA-B57/5801 and infected with the wild-type virus, the T242N escape appeared at 203. days (196-231) p/s, reached dominance at 277. days (265-315. days) p/s, and became complete at 323. days (289-373. days) p/s. HLA-B57/5801-negative subjects infected with 242N escape variant did not show reduced viral load or increased CD4 count. The study highlights the differential selection of T242N escape by HLA-B57 and B5801 and suggests that the presence of HLA-B57/5801-mediated immune pressure is able to control replication of the wild-type virus encoding Thr at Gag residue 242 but fails to suppress the T242N escape variant. © 2010 Elsevier Inc.
Authors & Co-Authors
Novitsky, Vladimir A.
United States, Boston
Harvard T.h. Chan School of Public Health Aids Initiative
Botswana, Gaborone
Botswana Harvard Aids Institute Partnership
Wang, Rui
United States, Boston
Harvard T.h. Chan School of Public Health
Margolin, Lauren
United States, Boston
Harvard T.h. Chan School of Public Health Aids Initiative
Baca, Jeannie
United States, Boston
Harvard T.h. Chan School of Public Health Aids Initiative
Moyo, Sikhulile M.
Botswana, Gaborone
Botswana Harvard Aids Institute Partnership
Musonda, Rosemary Mubanga
Botswana, Gaborone
Botswana Harvard Aids Institute Partnership
Essex, Max E.
United States, Boston
Harvard T.h. Chan School of Public Health Aids Initiative
Botswana, Gaborone
Botswana Harvard Aids Institute Partnership
Statistics
Citations: 25
Authors: 7
Affiliations: 3
Identifiers
Doi:
10.1016/j.virol.2010.04.001
ISSN:
00426822
e-ISSN:
10960341
Research Areas
Infectious Diseases
Study Design
Cohort Study